Showing results (81-90 of 175) with videos related to

Sort By:
Pageof 18
Gynecologic Oncology|September 19, 1998
Prolonged oral etoposide in recurrent or advanced leiomyosarcoma of the uterus: a gynecologic oncology group studyP G Rose, J A Blessing, J T Soper, et al.
Controlled Clinical Trials|March 1, 1987
Experience with the use of generalized data base management systems in cooperative group clinical trials (a project of the Gynecologic Oncology Group)J A Blessing, B N Bundy, P A Reese, et al.
American Journal of Obstetrics and Gynecology|April 15, 1985
Risk factors and recurrent patterns in Stage I endometrial cancerP J DiSaia, W T Creasman, R C Boronow, et al.
Gynecologic Oncology|April 1, 1994
A phase II trial of ifosfamide and mesna in patients with advanced or recurrent mixed mesodermal tumors of the ovary previously treated with platinum-based chemotherapy: a Gynecologic Oncology Group studyG P Sutton, J A Blessing, H D Homesley, et al.
Journal of Medical Systems|June 1, 1983
GOG meets RPMIS. Experience with computerized data management in a cooperative group settingP A Reese, B N Bundy, S P Colombano, et al.
American Journal of Clinical Oncology|June 1, 1984
Phase II trial of piperazinedione (NSC 135758) in the treatment of advanced or recurrent carcinoma of the ovary. A Gynecologic Oncology Group studyJ T Thigpen, J A Blessing, J C Arseneau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group studyP G Rose, J A Blessing, A R Mayer, et al.
Cancer|July 15, 1991
Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A Gynecologic Oncology Group study of second-line therapy in 105 patientsK D Hatch, J B Beecham, J A Blessing, et al.
Gynecologic Oncology|April 1, 1993
Phase II study of ifosfamide and mesna in nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group studyG P Sutton, J A Blessing, P J DiSaia, et al.
American Journal of Clinical Oncology|December 10, 1997
A phase II trial of amonafide in patients with nonsquamous cell carcinoma of the cervix. A Gynecologic Oncology Group studyR Asbury, J A Blessing, K Y Look, et al.
Pageof 18